• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombophilias and new oral anticoagulants, a safe alternative to warfarin?

作者信息

Pizzi G, Cotruzzola A M, Battaglia V

机构信息

Division of Anesthesiology and Intensive Care, Hospital "Madonna della Consolazione", Reggio Calabria, Italy.

Hospital "Busto Arsizio", Varese, Italy.

出版信息

Int J Cardiol. 2016 Oct 1;220:569-70. doi: 10.1016/j.ijcard.2016.06.299. Epub 2016 Jun 29.

DOI:10.1016/j.ijcard.2016.06.299
PMID:27390989
Abstract
摘要

相似文献

1
Thrombophilias and new oral anticoagulants, a safe alternative to warfarin?血栓形成倾向与新型口服抗凝药，华法林的安全替代品？
Int J Cardiol. 2016 Oct 1;220:569-70. doi: 10.1016/j.ijcard.2016.06.299. Epub 2016 Jun 29.
2
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.低剂量非维生素K拮抗剂口服抗凝药与华法林在房颤患者中的有效性和安全性：倾向评分加权的全国队列研究
BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510.
3
[Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].[非瓣膜性心房颤动患者中直接口服抗凝剂与维生素K拮抗剂相关因素]
Therapie. 2015 Nov-Dec;70(6):485-92. doi: 10.2515/therapie/2015032. Epub 2015 Jul 29.
4
Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?华法林还是醋硝香豆素：哪种在口服抗凝剂管理中更优？
Thromb Haemost. 1998 Dec;80(6):899-902.
5
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.达比加群、利伐沙班和华法林导致胃肠道出血的比较风险：基于人群的队列研究。
BMJ. 2015 Apr 24;350:h1857. doi: 10.1136/bmj.h1857.
6
Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.达比加群或利伐沙班与维生素K拮抗剂新治疗的非瓣膜性心房颤动患者出血和动脉血栓栓塞事件短期风险的比较：一项法国全国性倾向匹配队列研究。
Circulation. 2015 Sep 29;132(13):1252-60. doi: 10.1161/CIRCULATIONAHA.115.015710. Epub 2015 Jul 21.
7
Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.口服抗凝剂相关的胃肠道出血风险：基于人群的回顾性队列研究。
BMJ. 2015 Apr 24;350:h1585. doi: 10.1136/bmj.h1585.
8
Efficacy of new oral anticoagulants in patients with atrial fibrillation previously treated with warfarin: a meta-analysis of randomized controlled trials.新型口服抗凝药在既往接受华法林治疗的房颤患者中的疗效：一项随机对照试验的荟萃分析。
Int J Cardiol. 2014 Apr 15;173(1):122-4. doi: 10.1016/j.ijcard.2014.02.027. Epub 2014 Feb 22.
9
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.老年合并症心房颤动患者的卒中预防：聚焦于非维生素K拮抗剂口服抗凝药。
Clin Interv Aging. 2015 Sep 3;10:1431-44. doi: 10.2147/CIA.S80641. eCollection 2015.
10
Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin.用于直流电复律手术的新型口服抗凝剂：与华法林相比的使用情况及临床结局
Pacing Clin Electrophysiol. 2015 Jun;38(6):731-7. doi: 10.1111/pace.12618. Epub 2015 Apr 1.

引用本文的文献

1
Pharmacokinetics and Pharmacodynamics of a Depolymerized Glycosaminoglycan from , a Novel Anticoagulant Candidate, in Rats by Bioanalytical Methods.用生物分析方法研究新型抗凝候选药物 去聚合糖胺聚糖的药代动力学和药效动力学在大鼠中的表现。
Mar Drugs. 2021 Apr 11;19(4):212. doi: 10.3390/md19040212.
2
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report.利伐沙班作为房颤、易栓症和左心耳血栓患者华法林的有效替代药物：一例病例报告
J Med Case Rep. 2017 Apr 9;11(1):97. doi: 10.1186/s13256-017-1249-8.